Hematopoietic Stem Cells Transplantation (HSCT) Market to grow by USD 2,383.61 million from 2023 to 2027, North America to account for 40% of the market growth

NEW YORK, May 18, 2023 /PRNewswire/ — The hematopoietic stem cells transplantation (HSCT) market size is set to grow by USD 2383.61 million between 2023 and 2027, and register a CAGR of 6.5%, according Technavio’s latest market research report. With a focus on identifying dominant industry influencers, Technavio’s reports present a detailed study by way of synthesis, and summation of data from multiple sources. This report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment.

Technavio offers in-depth market insights that assist global businesses to obtain growth opportunities. Read Sample Report

Factors such as the availability of technologically advanced equipment, the increasing investments in the field of regenerative medicines, and the rising number of HSCTs will offer immense growth opportunities. To leverage the current opportunities, market vendors must strengthen their foothold in the fast-growing segments, while maintaining their positions in the slow-growing segments. The hematopoietic stem cell transplantation (HSCT) market is fragmented, and the degree of fragmentation will accelerate during the forecast period.

Hematopoietic Stem Cells Transplantation (HSCT) Market 2023-2027: Segmentation

• Application 
• Bone Marrow Transplant
• Peripheral Blood Stem Cell Transplant
• Cord Blood Transplant
• Type 
• Autologous HSCT
• Allogeneic HSCT
• Geography 
• North America
• Europe
• Asia
• Rest Of World (ROW)

Detail Insights on impact of each segment and make informed business decisions: https://www.technavio.com/talk-to-us?report=IRTNTR41656

Hematopoietic Stem Cells Transplantation (HSCT) Market 2023-2027: Vendor Analysis and Scope

Some of the major vendors of the hematopoietic stem cells transplantation (HSCT) market in l4 industry include Athersys Inc., Beike Biotechnology Co. Ltd., bluebird bio Inc., Cellular Biomedicine Group Inc., FUJIFILM Corp., Gamida Cell Ltd., Lineage Cell Therapeutics Inc., Lonza Group Ltd., MEDIPOST Co. Ltd., Merck and Co. Inc., Mesoblast Ltd., Pluristem Therapeutics Inc., Sanofi SA, Sartorius CellGenix GmbH, Taiga Biotechnologies Inc., Takeda Pharmaceutical Co. Ltd., Talaris Therapeutics Inc., ThermoGenesis Holdings Inc., and AllCells Corp.

To help businesses improve their market position, Technavio’s report provides a detailed analysis of around 15+ vendors operating in the market. To leverage the current opportunities, market vendors must strengthen their foothold in the fast-growing segments, while maintaining their positions in the slow-growing segments. Backed with competitive intelligence and benchmarking, our research reports on the hematopoietic stem cells transplantation (HSCT) market are designed to provide entry support, customer profile & M&As as well as go-to-market strategy support.

athersys.com- The company offers hematopoietic stem cell products such as bone marrow aspirates and cells, CD34 plus HSPCs isolated from bone marrow.

beikebiotech.com- The company offers hematopoietic stem cells transplantation namely MultiStem Treatment.

bluebirdbio.com- The company offers hematopoietic stem cells transplantation through its technology namely MAR, TriTE, MAR-T.

The report also covers the following areas:

Market trends such as growing demand for personalized medicine is likely to emerge as one of the primary drivers of the market. However, factors such as High cost of HSCT may threaten the growth of the market.

Market Driver

• Availability of technologically advanced equipment
• Increasing investments in field of regenerative medicines
• Rising number of HSCT

Market Trend

• Growing demand for personalized medicine
• Decreasing morbidity and mortality rate
• Advent of cord blood banking

Market Challenges

• High cost of HSCT
• Increased risk of complications post-HSCT
• Rising case of GvHD

Get lifetime access to our Technavio Insights. Subscribe now to our most popular “Lite Plan” billed annually at USD 5000. View 3 reports monthly and Download 3 Reports Annually!

Hematopoietic Stem Cells Transplantation (HSCT) Market 2023-2027: Key Highlights

• CAGR of the market during the forecast period 2023-2027
• Detailed information on factors that will assist hematopoietic stem cells transplantation (HSCT) market growth during the next five years
• Estimation of the hematopoietic stem cells transplantation (HSCT) market size and its contribution to the parent market
• Predictions on upcoming trends and changes in consumer behavior
• The growth of the hematopoietic stem cells transplantation (HSCT) market
• Analysis of the market’s competitive landscape and detailed information on vendors
• Comprehensive details of factors that will challenge the growth of hematopoietic stem cells transplantation (HSCT) market vendors

Related Reports:

Topical Corticosteroids Market- The topical corticosteroids market size is estimated to grow at a CAGR of 4% between 2022 and 2027. The market size is forecast to increase by USD 1,089.66 million.

Atopic Dermatitis Drugs Market- The atopic dermatitis drugs market size has the potential to grow by $ 4720.19 million during 2023-2027, and the market’s growth momentum will accelerate during the forecast period.

1 Executive Summary

• 1.1 Market overview 
• Exhibit 01: Executive Summary – Chart on Market Overview
• Exhibit 02: Executive Summary – Data Table on Market Overview
• Exhibit 03: Executive Summary – Chart on Global Market Characteristics
• Exhibit 04: Executive Summary – Chart on Market by Geography
• Exhibit 05: Executive Summary – Chart on Market Segmentation by Application
• Exhibit 06: Executive Summary – Chart on Market Segmentation by Type
• Exhibit 07: Executive Summary – Chart on Incremental Growth
• Exhibit 08: Executive Summary – Data Table on Incremental Growth
• Exhibit 09: Executive Summary – Chart on Vendor Market Positioning

2 Market Landscape

• 2.1 Market ecosystem 
• Exhibit 10: Parent market
• Exhibit 11: Market Characteristics

3 Market Sizing

• 3.1 Market definition 
• Exhibit 12: Offerings of vendors included in the market definition

• 3.2 Market segment analysis 
• Exhibit 13: Market segments

• 3.4 Market outlook: Forecast for 2022-2027
• Exhibit 14: Chart on Global – Market size and forecast 2022-2027 ($ million)
• Exhibit 15: Data Table on Global – Market size and forecast 2022-2027 ($ million)
• Exhibit 16: Chart on Global Market: Year-over-year growth 2022-2027 (%)
• Exhibit 17: Data Table on Global Market: Year-over-year growth 2022-2027 (%)

4 Historic Market Size

• 4.1 Global hematopoietic stem cells transplantation (HSCT) market 2017 – 2021 
• Exhibit 18: Historic Market Size – Data Table on Global hematopoietic stem cells transplantation (HSCT) market 2017 – 2021 ($ million)

• 4.2 Application Segment Analysis 2017 – 2021
• Exhibit 19: Historic Market Size – Application Segment 2017 – 2021 ($ million)

• 4.3 Type Segment Analysis 2017 – 2021 
• Exhibit 20: Historic Market Size – Type Segment 2017 – 2021 ($ million)

• 4.4 Geography Segment Analysis 2017 – 2021
• Exhibit 21: Historic Market Size – Geography Segment 2017 – 2021 ($ million)

• 4.5 Country Segment Analysis 2017 – 2021
• Exhibit 22: Historic Market Size – Country Segment 2017 – 2021 ($ million)

5 Five Forces Analysis

• 5.1 Five forces summary 
• Exhibit 23: Five forces analysis – Comparison between 2022 and 2027

• 5.2 Bargaining power of buyers 
• Exhibit 24: Chart on Bargaining power of buyers – Impact of key factors 2022 and 2027

• 5.3 Bargaining power of suppliers 
• Exhibit 25: Bargaining power of suppliers – Impact of key factors in 2022 and 2027

• 5.4 Threat of new entrants 
• Exhibit 26: Threat of new entrants – Impact of key factors in 2022 and 2027

• 5.5 Threat of substitutes 
• Exhibit 27: Threat of substitutes – Impact of key factors in 2022 and 2027

• 5.6 Threat of rivalry 
• Exhibit 28: Threat of rivalry – Impact of key factors in 2022 and 2027

• 5.7 Market condition 
• Exhibit 29: Chart on Market condition – Five forces 2022 and 2027

6 Market Segmentation by Application

• 6.1 Market segments 
• Exhibit 30: Chart on Application – Market share 2022-2027 (%)
• Exhibit 31: Data Table on Application – Market share 2022-2027 (%)

• 6.2 Comparison by Application 
• Exhibit 32: Chart on Comparison by Application
• Exhibit 33: Data Table on Comparison by Application

• 6.3 Bone marrow transplant – Market size and forecast 2022-2027 
• Exhibit 34: Chart on Bone marrow transplant – Market size and forecast 2022-2027 ($ million)
• Exhibit 35: Data Table on Bone marrow transplant – Market size and forecast 2022-2027 ($ million)
• Exhibit 36: Chart on Bone marrow transplant – Year-over-year growth 2022-2027 (%)
• Exhibit 37: Data Table on Bone marrow transplant – Year-over-year growth 2022-2027 (%)

• 6.4 Peripheral blood stem cell transplant – Market size and forecast 2022-2027 
• Exhibit 38: Chart on Peripheral blood stem cell transplant – Market size and forecast 2022-2027 ($ million)
• Exhibit 39: Data Table on Peripheral blood stem cell transplant – Market size and forecast 2022-2027 ($ million)
• Exhibit 40: Chart on Peripheral blood stem cell transplant – Year-over-year growth 2022-2027 (%)
• Exhibit 41: Data Table on Peripheral blood stem cell transplant – Year-over-year growth 2022-2027 (%)

• 6.5 Cord blood transplant – Market size and forecast 2022-2027 
• Exhibit 42: Chart on Cord blood transplant – Market size and forecast 2022-2027 ($ million)
• Exhibit 43: Data Table on Cord blood transplant – Market size and forecast 2022-2027 ($ million)
• Exhibit 44: Chart on Cord blood transplant – Year-over-year growth 2022-2027 (%)
• Exhibit 45: Data Table on Cord blood transplant – Year-over-year growth 2022-2027 (%)

• 6.6 Market opportunity by Application 
• Exhibit 46: Market opportunity by Application ($ million)

7 Market Segmentation by Type

• 7.1 Market segments 
• Exhibit 47: Chart on Type – Market share 2022-2027 (%)
• Exhibit 48: Data Table on Type – Market share 2022-2027 (%)

• 7.2 Comparison by Type 
• Exhibit 49: Chart on Comparison by Type
• Exhibit 50: Data Table on Comparison by Type

• 7.3 Autologous HSCT – Market size and forecast 2022-2027
• Exhibit 51: Chart on Autologous HSCT – Market size and forecast 2022-2027 ($ million)
• Exhibit 52: Data Table on Autologous HSCT – Market size and forecast 2022-2027 ($ million)
• Exhibit 53: Chart on Autologous HSCT – Year-over-year growth 2022-2027 (%)
• Exhibit 54: Data Table on Autologous HSCT – Year-over-year growth 2022-2027 (%)

• 7.4 Allogeneic HSCT – Market size and forecast 2022-2027
• Exhibit 55: Chart on Allogeneic HSCT – Market size and forecast 2022-2027 ($ million)
• Exhibit 56: Data Table on Allogeneic HSCT – Market size and forecast 2022-2027 ($ million)
• Exhibit 57: Chart on Allogeneic HSCT – Year-over-year growth 2022-2027 (%)
• Exhibit 58: Data Table on Allogeneic HSCT – Year-over-year growth 2022-2027 (%)

• 7.5 Market opportunity by Type 
• Exhibit 59: Market opportunity by Type ($ million)

8 Customer Landscape

• 8.1 Customer landscape overview 
• Exhibit 60: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria

9 Geographic Landscape

• 9.1 Geographic segmentation 
• Exhibit 61: Chart on Market share by geography 2022-2027 (%)
• Exhibit 62: Data Table on Market share by geography 2022-2027 (%)

• 9.2 Geographic comparison 
• Exhibit 63: Chart on Geographic comparison
• Exhibit 64: Data Table on Geographic comparison

• 9.3 North America – Market size and forecast 2022-2027
• Exhibit 65: Chart on North America – Market size and forecast 2022-2027 ($ million)
• Exhibit 66: Data Table on North America – Market size and forecast 2022-2027 ($ million)
• Exhibit 67: Chart on North America – Year-over-year growth 2022-2027 (%)
• Exhibit 68: Data Table on North America – Year-over-year growth 2022-2027 (%)

• 9.4 Europe – Market size and forecast 2022-2027
• Exhibit 69: Chart on Europe – Market size and forecast 2022-2027 ($ million)
• Exhibit 70: Data Table on Europe – Market size and forecast 2022-2027 ($ million)
• Exhibit 71: Chart on Europe – Year-over-year growth 2022-2027 (%)
• Exhibit 72: Data Table on Europe – Year-over-year growth 2022-2027 (%)

• 9.5 Asia – Market size and forecast 2022-2027
• Exhibit 73: Chart on Asia – Market size and forecast 2022-2027 ($ million)
• Exhibit 74: Data Table on Asia – Market size and forecast 2022-2027 ($ million)
• Exhibit 75: Chart on Asia – Year-over-year growth 2022-2027 (%)
• Exhibit 76: Data Table on Asia – Year-over-year growth 2022-2027 (%)

• 9.6 Rest of World (ROW) – Market size and forecast 2022-2027 
• Exhibit 77: Chart on Rest of World (ROW) – Market size and forecast 2022-2027 ($ million)
• Exhibit 78: Data Table on Rest of World (ROW) – Market size and forecast 2022-2027 ($ million)
• Exhibit 79: Chart on Rest of World (ROW) – Year-over-year growth 2022-2027 (%)
• Exhibit 80: Data Table on Rest of World (ROW) – Year-over-year growth 2022-2027 (%)

• 9.7 US – Market size and forecast 2022-2027
• Exhibit 81: Chart on US – Market size and forecast 2022-2027 ($ million)
• Exhibit 82: Data Table on US – Market size and forecast 2022-2027 ($ million)
• Exhibit 83: Chart on US – Year-over-year growth 2022-2027 (%)
• Exhibit 84: Data Table on US – Year-over-year growth 2022-2027 (%)

• 9.8 UK – Market size and forecast 2022-2027
• Exhibit 85: Chart on UK – Market size and forecast 2022-2027 ($ million)
• Exhibit 86: Data Table on UK – Market size and forecast 2022-2027 ($ million)
• Exhibit 87: Chart on UK – Year-over-year growth 2022-2027 (%)
• Exhibit 88: Data Table on UK – Year-over-year growth 2022-2027 (%)

• 9.9 Germany – Market size and forecast 2022-2027
• Exhibit 89: Chart on Germany – Market size and forecast 2022-2027 ($ million)
• Exhibit 90: Data Table on Germany – Market size and forecast 2022-2027 ($ million)
• Exhibit 91: Chart on Germany – Year-over-year growth 2022-2027 (%)
• Exhibit 92: Data Table on Germany – Year-over-year growth 2022-2027 (%)

• 9.10 Canada – Market size and forecast 2022-2027
• Exhibit 93: Chart on Canada – Market size and forecast 2022-2027 ($ million)
• Exhibit 94: Data Table on Canada – Market size and forecast 2022-2027 ($ million)
• Exhibit 95: Chart on Canada – Year-over-year growth 2022-2027 (%)
• Exhibit 96: Data Table on Canada – Year-over-year growth 2022-2027 (%)

• 9.11 China – Market size and forecast 2022-2027
• Exhibit 97: Chart on China – Market size and forecast 2022-2027 ($ million)
• Exhibit 98: Data Table on China – Market size and forecast 2022-2027 ($ million)
• Exhibit 99: Chart on China – Year-over-year growth 2022-2027 (%)
• Exhibit 100: Data Table on China – Year-over-year growth 2022-2027 (%)

• 9.12 Market opportunity by geography 
• Exhibit 101: Market opportunity by geography ($ million)

10 Drivers, Challenges, and Trends

• 10.3 Impact of drivers and challenges 
• Exhibit 102: Impact of drivers and challenges in 2022 and 2027

11 Vendor Landscape

• 11.2 Vendor landscape 
• Exhibit 103: Overview on Criticality of inputs and Factors of differentiation

• 11.3 Landscape disruption 
• Exhibit 104: Overview on factors of disruption

• 11.4 Industry risks 
• Exhibit 105: Impact of key risks on business

12 Vendor Analysis

• 12.1 Vendors covered 
• Exhibit 106: Vendors covered

• 12.2 Market positioning of vendors 
• Exhibit 107: Matrix on vendor position and classification

• 12.3 AllCells Corp. 
• Exhibit 108: AllCells Corp. – Overview
• Exhibit 109: AllCells Corp. – Product / Service
• Exhibit 110: AllCells Corp. – Key offerings

• 12.4 Athersys Inc. 
• Exhibit 111: Athersys Inc. – Overview
• Exhibit 112: Athersys Inc. – Product / Service
• Exhibit 113: Athersys Inc. – Key offerings

• 12.5 Beike Biotechnology Co. Ltd. 
• Exhibit 114: Beike Biotechnology Co. Ltd. – Overview
• Exhibit 115: Beike Biotechnology Co. Ltd. – Product / Service
• Exhibit 116: Beike Biotechnology Co. Ltd. – Key offerings

• 12.6 bluebird bio Inc. 
• Exhibit 117: bluebird bio Inc. – Overview
• Exhibit 118: bluebird bio Inc. – Product / Service
• Exhibit 119: bluebird bio Inc. – Key offerings

• 12.7 Cellular Biomedicine Group Inc. 
• Exhibit 120: Cellular Biomedicine Group Inc. – Overview
• Exhibit 121: Cellular Biomedicine Group Inc. – Product / Service
• Exhibit 122: Cellular Biomedicine Group Inc. – Key offerings

• 12.8 FUJIFILM Corp. 
• Exhibit 123: FUJIFILM Corp. – Overview
• Exhibit 124: FUJIFILM Corp. – Business segments
• Exhibit 125: FUJIFILM Corp. – Key news
• Exhibit 126: FUJIFILM Corp. – Key offerings
• Exhibit 127: FUJIFILM Corp. – Segment focus

• 12.9 Gamida Cell Ltd. 
• Exhibit 128: Gamida Cell Ltd. – Overview
• Exhibit 129: Gamida Cell Ltd. – Product / Service
• Exhibit 130: Gamida Cell Ltd. – Key offerings

• 12.10 Lineage Cell Therapeutics Inc. 
• Exhibit 131: Lineage Cell Therapeutics Inc. – Overview
• Exhibit 132: Lineage Cell Therapeutics Inc. – Product / Service
• Exhibit 133: Lineage Cell Therapeutics Inc. – Key offerings

• 12.11 Lonza Group Ltd. 
• Exhibit 134: Lonza Group Ltd. – Overview
• Exhibit 135: Lonza Group Ltd. – Business segments
• Exhibit 136: Lonza Group Ltd. – Key news
• Exhibit 137: Lonza Group Ltd. – Key offerings
• Exhibit 138: Lonza Group Ltd. – Segment focus

• 12.12 MEDIPOST Co. Ltd. 
• Exhibit 139: MEDIPOST Co. Ltd. – Overview
• Exhibit 140: MEDIPOST Co. Ltd. – Product / Service
• Exhibit 141: MEDIPOST Co. Ltd. – Key offerings

• 12.13 Merck and Co. Inc. 
• Exhibit 142: Merck and Co. Inc. – Overview
• Exhibit 143: Merck and Co. Inc. – Business segments
• Exhibit 144: Merck and Co. Inc. – Key news
• Exhibit 145: Merck and Co. Inc. – Key offerings
• Exhibit 146: Merck and Co. Inc. – Segment focus

• 12.14 Mesoblast Ltd. 
• Exhibit 147: Mesoblast Ltd. – Overview
• Exhibit 148: Mesoblast Ltd. – Product / Service
• Exhibit 149: Mesoblast Ltd. – Key offerings

• 12.15 Sanofi SA 
• Exhibit 150: Sanofi SA – Overview
• Exhibit 151: Sanofi SA – Business segments
• Exhibit 152: Sanofi SA – Key news
• Exhibit 153: Sanofi SA – Key offerings
• Exhibit 154: Sanofi SA – Segment focus

• 12.16 Takeda Pharmaceutical Co. Ltd. 
• Exhibit 155: Takeda Pharmaceutical Co. Ltd. – Overview
• Exhibit 156: Takeda Pharmaceutical Co. Ltd. – Product / Service
• Exhibit 157: Takeda Pharmaceutical Co. Ltd. – Key news
• Exhibit 158: Takeda Pharmaceutical Co. Ltd. – Key offerings

• 12.17 ThermoGenesis Holdings Inc. 
• Exhibit 159: ThermoGenesis Holdings Inc. – Overview
• Exhibit 160: ThermoGenesis Holdings Inc. – Product / Service
• Exhibit 161: ThermoGenesis Holdings Inc. – Key offerings

13 Appendix

• 13.1 Scope of the report 

• 13.2 Inclusions and exclusions checklist
• Exhibit 162: Inclusions checklist
• Exhibit 163: Exclusions checklist

• 13.3 Currency conversion rates for US$ 
• Exhibit 164: Currency conversion rates for US$

• 13.4 Research methodology 
• Exhibit 165: Research methodology
• Exhibit 166: Validation techniques employed for market sizing
• Exhibit 167: Information sources

• 13.5 List of abbreviations 
• Exhibit 168: List of abbreviations

About Us

Technavio is a leading global technology research and advisory company. Their research and analysis focus on emerging market trends and provides actionable insights to help businesses identify market opportunities and develop effective strategies to optimize their market positions. With over 500 specialized analysts, Technavio’s report library consists of more than 17,000 reports and counting, covering 800 technologies, spanning across 50 countries. Their client base consists of enterprises of all sizes, including more than 100 Fortune 500 companies. This growing client base relies on Technavio’s comprehensive coverage, extensive research, and actionable market insights to identify opportunities in existing and potential markets and assess their competitive positions within changing market scenarios.

Contact
Technavio Research
Jesse Maida
Media & Marketing Executive
US: +1 844 364 1100
UK: +44 203 893 3200
Email: [email protected]
Website: www.technavio.com/

SOURCE Technavio